2. Eubig PA, Aguiar A, Schantz SL. Lead and PCBs as risk factors for attention deficit/hyperactivity disorder. Environ Health Perspect. 2010; 118:1654–67. DOI:
10.1289/ehp.0901852. PMID:
20829149.
3. Mu Muntner P, Menke A, DeSalvo K, Rabito F, Batuman V. Continued decline in blood lead levels among adults in the United States: the National Health and Nutrition Examination Surveys. Arch Intern Med. 2005; 165:2155–61. DOI:
10.1001/archinte.165.18.2155. PMID:
16217007.
4. Gracia RC, Snodgrass WR. Lead toxicity and chelation therapy. Am J Health Syst Pharm. 2007; 64:45–53. DOI:
10.2146/ajhp060175. PMID:
17189579.
7. Hultberg B, Andersson A, Isaksson A. Interaction of metals and thiols in cell damage and glutathione distribution: potentiation of mercury toxicity by dithiothreitol. Toxicology. 2001; 156:93–100. DOI:
10.1016/S0300-483X(00)00331-0. PMID:
11164611.
8. Ahamed M, Siddiqui MK. Low level lead exposure and oxidative stress: current opinions. Clin Chim Acta. 2007; 383:57–64. DOI:
10.1016/j.cca.2007.04.024. PMID:
17573057.
9. Patrick L. Lead toxicity part II: the role of free radical damage and the use of antioxidants in the pathology and treatment of lead toxicity. Altern Med Rev. 2006; 11:114–27. PMID:
16813461.
10. Garza A, Vega R, Soto E. Cellular mechanisms of lead neurotoxicity. Med Sci Monit. 2006; 12:RA57–65. PMID:
16501435.
11. Bressler J, Kim KA, Chakraborti T, Goldstein G. Molecular mechanisms of lead neurotoxicity. Neurochem Res. 1999; 24:595–600. DOI:
10.1023/A:1022596115897. PMID:
10227691.
12. Cory-Slechta DA. Legacy of lead exposure: consequences for the central nervous system. Otolaryngol Head Neck Surg. 1996; 114:224–6. DOI:
10.1016/S0194-5998(96)70171-7. PMID:
8637738.
13. Bellinger DC. Lead. Pediatrics. 2004; 113:1016–22. PMID:
15060194.
14. Flora SJS, Flora G, Saxena G. Environmental occurrence, health effects and management of lead poisoning. 2006. Amsterdam: Elsevier Publication.
15. Sanders T, Liu Y, Buchner V, Tchounwou PB. Neurotoxic effects and biomarkers of lead exposure: a review. Rev Environ Health. 2009; 24:15–45. DOI:
10.1515/REVEH.2009.24.1.15. PMID:
19476290.
16. Ahamed M, Verma S, Kumar A, Siddiqui MK. Environmental exposure to lead and its correlation with biochemical indices in children. Sci Total Environ. 2005; 346:48–55. DOI:
10.1016/j.scitotenv.2004.12.019. PMID:
15993681.
17. Vij A. Hemopoietic, hemostatic and mutagenic effects of lead and possible prevention by zinc and vitamin C. Al Ameen J Med Sci. 2009; 2:27–36.
18. Navas-Acien A, Guallar E, Silbergeld EK, Rothenberg SJ. Lead exposure and cardiovascular disease--a systematic review. Environ Health Perspect. 2007; 115:472–82. DOI:
10.1289/ehp.9785. PMID:
17431501.
20. Nawrot TS, Thijs L, Den Hond EM, Roels HA, Staessen JA. An epidemiological re-appraisal of the association between blood pressure and blood lead: a meta-analysis. J Hum Hypertens. 2002; 16:123–31. DOI:
10.1038/sj.jhh.1001300. PMID:
11850770.
21. Sirivarasai J, Kaojarern S, Chanprasertyothin S, Panpunuan P, Petchpoung K, Tatsaneeyapant A, et al. Environmental lead exposure, catalase gene, and markers of antioxidant and oxidative stress relation to hypertension: an analysis based on the EGAT study. Biomed Res Int. 2015; 2015:856319. DOI:
10.1155/2015/856319. PMID:
25793211.
22. Rastogi SK. Renal effects of environmental and occupational lead exposure. Indian J Occup Environ Med. 2008; 12:103–6. DOI:
10.4103/0019-5278.44689. PMID:
20040966.
24. Kemp FW, Neti PV, Howell RW, Wenger P, Louria DB, Bogden JD. Elevated blood lead concentrations and vitamin D deficiency in winter and summer in young urban children. Environ Health Perspect. 2007; 115:630–5. DOI:
10.1289/ehp.9389. PMID:
17450235.
25. Katzung BG. Basic and clinical pharmacology: McGraw Hill Professional. 2007.
26. Goldfrank LR, Flomenbaum N. Goldfrank's toxicologic emergencies. 8th ed. New York: McGraw Hill Professional; 2006.
28. Hilal-Dandan R, Brunton L. Goodman and Gilman's manual of pharmacology and therapeutics. 2nd ed. New Delhi: McGraw Hill Professional; 2013.
29. Patrick L. Lead toxicity, a review of the literature. Part 1: exposure, evaluation, and treatment. Altern Med Rev. 2006; 11:2–22. PMID:
16597190.
30. Josef R. Industrial poisoning from fumes, gases and poisons of manufacturing processes. HardPress Publishing; 2013.
31. Taylor CM, Golding J, Emond AM. Adverse effects of maternal lead levels on birth outcomes in the ALSPAC study: a prospective birth cohort study. BJOG. 2015; 122:322–8. DOI:
10.1111/1471-0528.12756. PMID:
24824048.
32. Landrigan PJ, Schechter CB, Lipton JM, Fahs MC, Schwartz J. Environmental pollutants and disease in American children: estimates of morbidity, mortality, and costs for lead poisoning, asthma, cancer, and developmental disabilities. Environ Health Perspect. 2002; 110:721–8. DOI:
10.1289/ehp.02110721. PMID:
12117650.
33. Wu A. Tietz clinical guide to laboratory tests. 2006. 4. St. Louis: Saunders Elsevier.
34. Centers for Disease Control and Prevention's Advisory Committee for Childhood Lead Poisoning Prevention. Recommendations in Low level lead exposure harms children: a renewed call of primary prevention. 2012.
36. Baselt RC. Disposition of toxic drugs and chemicals in man. 9th ed. Foster City, California: Biomedical Publications; 2011.
37. Smith DR, Osterloh JD, Flegal AR. Use of endogenous, stable lead isotopes to determine release of lead from the skeleton. Environ Health Perspect. 1996; 104:60–6. DOI:
10.1289/ehp.9610460. PMID:
8834863.
38. Gulson BL, Mizon KJ, Korsch MJ, Palmer JM, Donnelly JB. Mobilization of lead from human bone tissue during pregnancy and lactation--a summary of long-term research. Sci Total Environ. 2003; 303:79–104. DOI:
10.1016/S0048-9697(02)00355-8. PMID:
12568766.
39. Khalil N, Faulkner KA, Greenspan SL, Cauley JA. Associations between bone mineral density, grip strength, and lead body burden in older men. J Am Geriatr Soc. 2014; 62:141–6. DOI:
10.1111/jgs.12603. PMID:
24383935.
40. Hu H, Rabinowitz M, Smith D. Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms. Environ Health Perspect. 1998; 106:1–8. DOI:
10.1289/ehp.981061. PMID:
9417769.
41. Yu CC, Lin JL, Lin-Tan DT. Environmental exposure to lead and progression of chronic renal diseases: a four-year prospective longitudinal study. J Am Soc Nephrol. 2004; 15:1016–22. DOI:
10.1097/01.ASN.0000118529.01681.4F. PMID:
15034104.
42. Barry PS. A comparison of concentrations of lead in human tissues. Br J Ind Med. 1975; 32:119–39. PMID:
1131339.
43. Philip AT, Gerson B. Lead poisoning--Part II. Effects and assay. Clin Lab Med. 1994; 14:651–70. PMID:
7805350.
45. Smith CM, Wang X, Hu H, Kelsey KT. A polymorphism in the delta-aminolevulinic acid dehydratase gene may modify the pharmacokinetics and toxicity of lead. Environ Health Perspect. 1995; 103:248–53. PMID:
7768225.
46. Somashekaraiah BV, Venkaiah B, Prasad AR. Biochemical diagnosis of occupational exposure to lead toxicity. Bull Environ Contam Toxicol. 1990; 44:268–75. DOI:
10.1007/BF01700146. PMID:
2322668.
47. Paglia DE, Valentine WN, Fink K. Lead poisoning. Further observations on erythrocyte pyrimidine-nucleotidase deficiency and intracellular accumulation of pyrimidine nucleotides. J Clin Invest. 1977; 60:1362–6. DOI:
10.1172/JCI108896. PMID:
915002.
48. Flora SJ, Pachauri V. Chelation in metal intoxication. Int J Environ Res Public Health. 2010; 7:2745–88. DOI:
10.3390/ijerph7072745. PMID:
20717537.
49. Bradberry S, Vale A. Dimercaptosuccinic acid (succimer; DMSA) in inorganic lead poisoning. Clin Toxicol (Phila). 2009; 47:617–31. DOI:
10.1080/15563650903174828. PMID:
19663612.
50. Sears ME. Chelation: harnessing and enhancing heavy metal detoxification--a review. ScientificWorldJournal. 2013; 2013:219840. DOI:
10.1155/2013/219840. PMID:
23690738.
51. Shannon MW, Townsend MK. Adverse effects of reduced-dose d-penicillamine in children with mild-to-moderate lead poisoning. Ann Pharmacother. 2000; 34:15–8. DOI:
10.1345/aph.19084. PMID:
10669180.
52. McKay CA Jr. Role of chelation in the treatment of lead poisoning: discussion of the Treatment of Lead-Exposed Children Trial (TLC). J Med Toxicol. 2013; 9:339–43. DOI:
10.1007/s13181-013-0341-8. PMID:
24178899.
53. Senapati SK, Dey S, Dwivedi SK, Patra RC, Swarup D. Effect of thiamine hydrochloride on lead induced lipid peroxidation in rat liver and kidney. Vet Hum Toxicol. 2000; 42:236–7. PMID:
10928693.
54. Lee YM, Lee MK, Bae SG, Lee SH, Kim SY, Lee DH. Association of homocysteine levels with blood lead levels and micronutrients in the US general population. J Prev Med Public Health. 2012; 45:387–93. DOI:
10.3961/jpmph.2012.45.6.387. PMID:
23230469.
55. Chang BJ, Jang BJ, Son TG, Cho IH, Quan FS, Choe NH, et al. Ascorbic acid ameliorates oxidative damage induced by maternal low-level lead exposure in the hippocampus of rat pups during gestation and lactation. Food Chem Toxicol. 2012; 50:104–8. DOI:
10.1016/j.fct.2011.09.043. PMID:
22056337.
56. Shalan MG, Mostafa MS, Hassouna MM, El-Nabi SE, El-Refaie A. Amelioration of lead toxicity on rat liver with Vitamin C and silymarin supplements. Toxicology. 2005; 206:1–15. DOI:
10.1016/j.tox.2004.07.006. PMID:
15590105.
57. Tandon SK, Chatterjee M, Bhargava A, Shukla V, Bihari V. Lead poisoning in Indian silver refiners. Sci Total Environ. 2001; 281:177–82. DOI:
10.1016/S0048-9697(01)00845-2. PMID:
11778950.
58. Tariq SA. Role of ascorbic acid in scavenging free radicals and lead toxicity from biosystems. Mol Biotechnol. 2007; 37:62–5. DOI:
10.1007/s12033-007-0045-x. PMID:
17914166.
59. Takatsu H, Owada K, Abe K, Nakano M, Urano S. Effect of vitamin E on learning and memory deficit in aged rats. J Nutr Sci Vitaminol (Tokyo). 2009; 55:389–93. DOI:
10.3177/jnsv.55.389. PMID:
19926923.
60. Sajitha GR, Jose R, Andrews A, Ajantha KG, Augustine P, Augusti KT. Garlic oil and vitamin E prevent the adverse effects of lead acetate and ethanol separately as well as in combination in the drinking water of rats. Indian J Clin Biochem. 2010; 25:280–8. DOI:
10.1007/s12291-010-0042-x. PMID:
21731199.
61. Khodamoradi N, Komaki A, Salehi I, Shahidi S, Sarihi A. Effect of vitamin E on lead exposure-induced learning and memory impairment in rats. Physiol Behav. 2015; 144:90–4. DOI:
10.1016/j.physbeh.2015.03.015. PMID:
25777497.
62. Liu CM, Ma JQ, Sun YZ. Protective role of puerarin on lead-induced alterations of the hepatic glutathione antioxidant system and hyperlipidemia in rats. Food Chem Toxicol. 2011; 49:3119–27. DOI:
10.1016/j.fct.2011.09.007. PMID:
22001170.
63. Boots AW, Haenen GR, Bast A. Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol. 2008; 585:325–37. DOI:
10.1016/j.ejphar.2008.03.008. PMID:
18417116.
64. Liu CM, Ma JQ, Sun YZ. Quercetin protects the rat kidney against oxidative stress-mediated DNA damage and apoptosis induced by lead. Environ Toxicol Pharmacol. 2010; 30:264–71. DOI:
10.1016/j.etap.2010.07.002. PMID:
21787659.
65. Liu CM, Zheng GH, Ming QL, Sun JM, Cheng C. Protective effect of quercetin on lead-induced oxidative stress and endoplasmic reticulum stress in rat liver via the IRE1/JNK and PI3K/Akt pathway. Free Radic Res. 2013; 47:192–201. DOI:
10.3109/10715762.2012.760198. PMID:
23249147.
66. Liu CM, Zheng GH, Cheng C, Sun JM. Quercetin protects mouse brain against lead-induced neurotoxicity. J Agric Food Chem. 2013; 61:7630–5. DOI:
10.1021/jf303387d. PMID:
23855546.
67. Flora SJ, Flora G, Saxena G, Mishra M. Arsenic and lead induced free radical generation and their reversibility following chelation. Cell Mol Biol (Noisy-le-grand). 2007; 53:26–47. PMID:
17519110.
68. Sivaprasad R, Nagaraj M, Varalakshmi P. Combined efficacies of lipoic acid and meso-2,3-dimercaptosuccinic acid on lead-induced erythrocyte membrane lipid peroxidation and antioxidant status in rats. Hum Exp Toxicol. 2003; 22:183–92. DOI:
10.1191/0960327103ht335oa. PMID:
12755469.
69. Pande M, Flora SJ. Lead induced oxidative damage and its response to combined administration of alpha-lipoic acid and succimers in rats. Toxicology. 2002; 177:187–96. DOI:
10.1016/S0300-483X(02)00223-8. PMID:
12135622.
70. Waseem N, Butt SA, Hamid S. Amelioration of lead induced changes in ovary of mice, by garlic extract. J Pak Med Assoc. 2014; 64:798–801. PMID:
25255589.
71. Buettner C, Mukamal KJ, Gardiner P, Davis RB, Phillips RS, Mittleman MA. Herbal supplement use and blood lead levels of United States adults. J Gen Intern Med. 2009; 24:1175–82. DOI:
10.1007/s11606-009-1050-5. PMID:
19575271.
72. Kianoush S, Balali-Mood M, Mousavi SR, Moradi V, Sadeghi M, Dadpour B, et al. Comparison of therapeutic effects of garlic and d-Penicillamine in patients with chronic occupational lead poisoning. Basic Clin Pharmacol Toxicol. 2011; 110:476–81. DOI:
10.1111/j.1742-7843.2011.00841.x. PMID:
22151785.
73. Shukla PK, Khanna VK, Khan MY, Srimal RC. Protective effect of curcumin against lead neurotoxicity in rat. Hum Exp Toxicol. 2003; 22:653–8. DOI:
10.1191/0960327103ht411oa. PMID:
14992327.